Evidence map›Paper›PMID 29928608›Full record

ReviewQuantitative imaging in medicine and surgery2018

Recent advances in nanoparticle carriers for photodynamic therapy.

Gawon Yi, Suk Ho Hong, Jihwan Son, Jihye Yoo, Changhee Park, Yongdoo Choi, Heebeom Koo

Open access · hybridAbstract readReview
In one paragraph

Review in Quantitative imaging in medicine and surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 102 citations in OpenAlex.

  1. Light as a Weapon: Redefining Cancer Care with Photodynamic Therapy.International journal of biological sciences · 2026
    Review
  2. Review
  3. Review
  4. Recent Cutting-Edge Technologies for the Delivery of Peptide Nucleic Acid.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Gawon YiDepartment of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Suk Ho HongBiomarker Branch, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.
Jihwan SonDepartment of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Jihye YooDepartment of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Changhee ParkDepartment of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Yongdoo ChoiBiomarker Branch, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.
Heebeom KooDepartment of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Catholic University of Korea · KRNational Cancer Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review summarizes recent advances in the development of nanoparticles (NPs) for efficient photodynamic therapy (PDT), particularly the development and application of various NPs based on organic and inorganic materials. PubMed database was used for literature search with the terms including NP, nanomedicine, PDT, photosensitizer (PSs), and drug delivery. For successful PDT, it is essential to deliver PSs to target disease sites. A number of NPs have been developed and tested as the carriers for both imaging and therapy, an approach termed "nanomedicine". Many studies of NP carriers showed increased water solubility and stability of PSs for

Indexed as

drug deliveryimagingnanomedicinenanoparticle (NP)Photodynamic therapy (PDT)

Identifiers

PMID29928608
PMCPMC5989095
OpenAlexW2804712565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.